Logo image of APAC

STONEBRIDGE ACQUISITION CORP (APAC) Stock Fundamental Analysis

NASDAQ:APAC - Nasdaq - KYG850941033 - Common Stock - Currency: USD

11.7  +3.52 (+43.03%)

After market: 15.5601 +3.86 (+32.99%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to APAC. APAC was compared to 0 industry peers in the Unkown industry. APAC may be in some trouble as it scores bad on both profitability and health. APAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year APAC was profitable.
APAC had a positive operating cash flow in the past year.
APAC Yearly Net Income VS EBIT VS OCF VS FCFAPAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 2M 4M 6M 8M 10M

1.2 Ratios

Industry RankSector Rank
ROA 6.42%
ROE 12.89%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APAC Yearly ROA, ROE, ROICAPAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 1 2 3 4 5

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for APAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APAC Yearly Profit, Operating, Gross MarginsAPAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for APAC remains at a similar level compared to 1 year ago.
APAC has a worse debt/assets ratio than last year.
APAC Yearly Shares OutstandingAPAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M
APAC Yearly Total Debt VS Total AssetsAPAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

APAC has an Altman-Z score of 1.51. This is a bad value and indicates that APAC is not financially healthy and even has some risk of bankruptcy.
APAC has a debt to FCF ratio of 2.52. This is a good value and a sign of high solvency as APAC would need 2.52 years to pay back of all of its debts.
APAC has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.52
Altman-Z 1.51
ROIC/WACCN/A
WACCN/A
APAC Yearly LT Debt VS Equity VS FCFAPAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

APAC has a Current Ratio of 0.03. This is a bad value and indicates that APAC is not financially healthy enough and could expect problems in meeting its short term obligations.
APAC has a Quick Ratio of 0.03. This is a bad value and indicates that APAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
APAC Yearly Current Assets VS Current LiabilitesAPAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for APAC have decreased strongly by -72.22% in the last year.
EPS 1Y (TTM)-72.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 117.00, APAC can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of APAC to the average of the S&P500 Index (27.45), we can say APAC is valued expensively.
Industry RankSector Rank
PE 117
Fwd PE N/A
APAC Price Earnings VS Forward Price EarningsAPAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 57.25
EV/EBITDA N/A
APAC Per share dataAPAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

APAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STONEBRIDGE ACQUISITION CORP

NASDAQ:APAC (4/2/2024, 8:01:24 PM)

After market: 15.5601 +3.86 (+32.99%)

11.7

+3.52 (+43.03%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner Change0%
Market Cap58.97M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 117
Fwd PE N/A
P/S N/A
P/FCF 57.25
P/OCF 57.25
P/B 4.37
P/tB 4.37
EV/EBITDA N/A
EPS(TTM)0.1
EY0.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.2
FCFY1.75%
OCF(TTM)0.2
OCFY1.75%
SpS0
BVpS2.68
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.42%
ROE 12.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.52
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 59.2%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 1.51
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.64%
OCF growth 3YN/A
OCF growth 5YN/A